Cascade of care of people diagnosed with HIV in New Zealand between 2006 and 2017

被引:1
作者
McAllister, S. [1 ]
vanAsten, H. [1 ]
Anglemyer, A. [1 ]
Crengle, S. [2 ]
Zeng, J. [2 ]
Raymond, N. [3 ]
Handy, R. [4 ]
Giola, M. [5 ,6 ]
Dickson, N. [1 ]
Priest, P. [1 ]
机构
[1] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, AIDS Epidemiol Grp, Dunedin, New Zealand
[2] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand
[3] Capital & Coast Dist Hlth Board, Wellington, New Zealand
[4] Auckland Dist Hlth Board, Auckland, New Zealand
[5] Bay Plenty & Lakes Dist Hlth Board, Tauranga, New Zealand
[6] Bay Plenty & Lakes Dist Hlth Board, Rotorua, New Zealand
关键词
antiretroviral therapy; cascade; HIV; viral load; ANTIRETROVIRAL THERAPY; PREVENTION; TRANSMISSION;
D O I
10.1111/hiv.12983
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives We estimated the proportion of people reported with HIV in New Zealand between 2006 and 2017, and alive in 2017-2019, who were on antiretroviral therapy (ART) and had a suppressed viral load (VL), and explored their associated characteristics. Methods Data were anonymously linked to information on ART and VL within the data collection period (January 2017 to August 2019) using the National Health Index (NHI), Ministry of Health and laboratory datasets, as well as information from clinical specialists. Logistic regression was used to test for associations. Sensitivity analyses were undertaken to estimate the range for the key proportions. Results Overall, 2355 people were reported with HIV, of whom 116 (5%) had died, 337 (14%) were overseas, and 1701 (72%) were alive in New Zealand; for the remaining 201 (9%) the outcome was unknown. Clinical data were available for 1490 people (87.6%): 1408 (94.5%) were on ART, 11 (< 1%) were not on ART, and for 71 (4.8%) this was unknown. Of those on ART, 1156 (82.1%) had a suppressed VL (< 200 copies/mL), 34 (2.4%) were unsuppressed, and for 218 (15.5%) this was unknown. The estimate of the proportion on ART ranged from 99% to 78%, and those with a suppressed VL ranged from 98% to 78%. Conclusions Among people with HIV in New Zealand who are under care, a high proportion were on ART and had suppressed VL. Increasing collection of NHIs and better linkage with laboratory information will reduce the number with unknown information and provide more complete VL results in the future.
引用
收藏
页码:122 / 130
页数:9
相关论文
共 21 条
[1]   Early initiation of antiretroviral therapy in HIV-infected adults and adolescents: a systematic review [J].
Anglemyer, Andrew ;
Rutherford, George W. ;
Easterbrook, Philippa J. ;
Horvath, Tara ;
Vitoria, Marco ;
Jan, Michael ;
Doherty, Meg C. .
AIDS, 2014, 28 :S105-S118
[2]  
Anglemyer A, 2013, JAMA-J AM MED ASSOC, V310, P1619, DOI [10.1001/jama.2013.278328, 10.1002/14651858.CD009153, 10.1002/14651858.CD009153.pub3]
[3]   HIV treatment as prevention among men who have sex with men in the UK: is transmission controlled by universal access to HIV treatment and care? [J].
Brown, A. E. ;
Gill, O. N. ;
Delpech, V. C. .
HIV MEDICINE, 2013, 14 (09) :563-570
[4]   Antiretroviral Therapy for the Prevention of HIV-1 Transmission [J].
Cohen, M. S. ;
Chen, Y. Q. ;
McCauley, M. ;
Gamble, T. ;
Hosseinipour, M. C. ;
Kumarasamy, N. ;
Hakim, J. G. ;
Kumwenda, J. ;
Grinsztejn, B. ;
Pilotto, J. H. S. ;
Godbole, S. V. ;
Chariyalertsak, S. ;
Santos, B. R. ;
Mayer, K. H. ;
Hoffman, I. F. ;
Eshleman, S. H. ;
Piwowar-Manning, E. ;
Cottle, L. ;
Zhang, X. C. ;
Makhema, J. ;
Mills, L. A. ;
Panchia, R. ;
Faesen, S. ;
Eron, J. ;
Gallant, J. ;
Havlir, D. ;
Swindells, S. ;
Elharrar, V. ;
Burns, D. ;
Taha, T. E. ;
Nielsen-Saines, K. ;
Celentano, D. D. ;
Essex, M. ;
Hudelson, S. E. ;
Redd, A. D. ;
Fleming, T. R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (09) :830-839
[5]  
Dickson N, 2015, NEW ZEAL MED J, V128, P31
[6]   The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection [J].
Gardner, Edward M. ;
McLees, Margaret P. ;
Steiner, John F. ;
del Rio, Carlos ;
Burman, William J. .
CLINICAL INFECTIOUS DISEASES, 2011, 52 (06) :793-800
[7]   Sweden, the first country to achieve the Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) 90-90-90 continuum of HIV care targets [J].
Gisslen, M. ;
Svedhem, V. ;
Lindborg, L. ;
Flamholc, L. ;
Norrgren, H. ;
Wendahl, S. ;
Axelsson, M. ;
Sonnerborg, A. .
HIV MEDICINE, 2017, 18 (04) :305-307
[8]   Status and methodology of publicly available national HIV care continua and 90-90-90 targets: A systematic review [J].
Granich, Reuben ;
Gupta, Somya ;
Hall, Irene ;
Aberle-Grasse, John ;
Hader, Shannon ;
Mermin, Jonathan .
PLOS MEDICINE, 2017, 14 (04)
[9]  
Kirby Institute, 2018, HIV AUSTR ANN SURV S
[10]   The HIV care cascade: a systematic review of data sources, methodology and comparability [J].
Medland, Nicholas A. ;
McMahon, James H. ;
Chow, Eric P. F. ;
Elliott, Julian H. ;
Hoy, Jennifer F. ;
Fairley, Christopher K. .
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2015, 18